Finally, a Treatment That Addresses the Root Cause of PCOS
PCOS is driven by insulin resistance and hormonal imbalance — not willpower. Our GLP-1 program targets the metabolic root of PCOS to help restore hormonal balance, regulate your cycle, and achieve lasting weight loss.
PCOS Is a Metabolic Condition, Not Just a Reproductive One
Polycystic Ovary Syndrome (PCOS) affects approximately 1 in 10 women of reproductive age, making it one of the most common hormonal disorders worldwide. Despite its name, PCOS is fundamentally a metabolic condition rooted in insulin resistance and androgen excess.
When the body becomes resistant to insulin, the pancreas compensates by producing more. Excess insulin signals the ovaries to produce more testosterone, disrupting the hormonal balance that governs ovulation, menstrual cycles, and overall metabolic health.
Traditional treatments like birth control pills and metformin address symptoms in isolation. GLP-1 receptor agonists work differently — by directly improving insulin sensitivity, they address the metabolic driver that underlies most PCOS symptoms.
Important Note
GLP-1 medications are not FDA-approved specifically for PCOS but are prescribed off-label based on robust clinical evidence. All prescriptions are issued by licensed physicians who review your complete health history.
The PCOS Cycle
Do Any of These Sound Familiar?
PCOS presents differently in every woman. If you experience several of these symptoms, a physician evaluation may help determine if PCOS is the underlying cause.
Irregular Periods
Infrequent, irregular, or prolonged menstrual cycles are the most common sign of PCOS.
Weight Gain
Difficulty losing weight or unexplained weight gain, especially around the abdomen.
Insulin Resistance
Up to 80% of women with PCOS have insulin resistance, increasing diabetes risk.
Elevated Androgens
Excess male hormones cause acne, excess facial/body hair, and hair thinning.
Fatigue & Low Energy
Hormonal imbalances and blood sugar dysregulation lead to persistent fatigue.
Metabolic Complications
Elevated cholesterol, triglycerides, and increased risk of type 2 diabetes.
How GLP-1 Medications Address PCOS
GLP-1 receptor agonists work through multiple pathways to address the metabolic and hormonal imbalances that drive PCOS symptoms.
Reduces Insulin Resistance
GLP-1 medications stimulate insulin release in a glucose-dependent manner, directly targeting the metabolic root cause of PCOS. Improved insulin sensitivity reduces compensatory hyperinsulinemia — the driver of elevated androgens.
Promotes Meaningful Weight Loss
Clinical trials show 10–15% body weight reduction with semaglutide and up to 20% with tirzepatide. Even modest weight loss of 5–10% can significantly improve PCOS symptoms, hormone levels, and menstrual regularity.
Lowers Testosterone Levels
Multiple studies confirm that GLP-1 receptor agonists reduce free and total testosterone levels in women with PCOS. Lower androgens translate to improvements in acne, hirsutism (excess hair), and hormonal balance.
Restores Menstrual Regularity
By improving insulin sensitivity and reducing androgen levels, GLP-1 medications help restore ovulatory function. Clinical evidence shows improved menstrual cycle regularity in a significant proportion of treated women.
Improves Cardiovascular Markers
Women with PCOS face elevated cardiovascular risk. GLP-1 medications reduce triglycerides, improve HDL cholesterol, and lower blood pressure — addressing the broader metabolic syndrome that often accompanies PCOS.
Reduces Inflammation
Chronic low-grade inflammation is a hallmark of PCOS. GLP-1 receptor agonists have demonstrated anti-inflammatory effects that may contribute to improved ovarian function and overall hormonal health.
Backed by Peer-Reviewed Research
The evidence supporting GLP-1 medications for PCOS management continues to grow.
GLP-1 RAs significantly reduced BMI, waist circumference, and total testosterone in women with PCOS
De Hollanda et al., 2024 — Metabolism
Liraglutide treatment resulted in improved menstrual bleeding regularity, decreased ovarian volume, and reduced free testosterone levels
Monney et al., 2025 — PMC
GLP-1 RAs may reduce serum androgen levels, enhance ovulatory function, and support menstrual cycle normalization
Hoteit et al., 2025 — PMC
* These statements are based on published clinical research. Individual results vary. GLP-1 medications are prescribed off-label for PCOS by licensed physicians.
Choose Your PCOS Program
Both medications are available as compounded formulations at a fraction of the branded cost. Your physician will recommend the right option based on your health history and goals.
Semaglutide
GLP-1 Receptor Agonist
- Weekly subcutaneous injection
- Average 10–15% body weight loss
- Proven testosterone reduction
- Improved menstrual regularity
- Licensed physician evaluation
- Monthly medication supply
- Ongoing care team support
Includes peptide-enhanced formulation to support fat loss while preserving lean muscle
Tirzepatide
GLP-1 + GIP Dual Agonist
- Weekly subcutaneous injection
- Average 15–20% body weight loss
- Dual hormone action (GLP-1 + GIP)
- Superior insulin sensitization
- Licensed physician evaluation
- Monthly medication supply
- Ongoing care team support
Dual-agonist mechanism may provide enhanced metabolic benefits for complex PCOS cases
All medications are compounded formulations prepared by licensed, accredited pharmacies. Prices shown are for monthly supply; multi-month plans available at a discount.
Getting Started Is Simple
Complete Health Assessment
Answer a brief questionnaire about your PCOS symptoms, medical history, and goals. Takes about 5 minutes.
Physician Review
A licensed physician reviews your information and determines if GLP-1 treatment is appropriate for you — within 24 hours.
Prescription Issued
If approved, your prescription is sent to a licensed compounding pharmacy and shipped directly to your door.
Ongoing Care
Your care team monitors your progress, adjusts dosing as needed, and is available to answer questions throughout your program.